Our Workstreams
An initiative by leading Biopharmaceutical companies in the world to establish Singapore as the country of choice for global biomedical sciences manufacturing.
We work closely with expertise from BMAC companies to improvise the Manufacturing Execution System (MES). These are the key areas under MES:
• Improve pharma manufacturing operations from ground up while maintaining product quality and speed to market
• Ensure seamless flow of information with greater transparency
• Schedule for regular maintenance and equipment upgrade
• Provide timely feedback and areas of improvement to MES vendors